13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001835943
Total reported value
$1.6B
$1.6B
43 檔
25.2%
According to the latest 13F quarterly dataset, AIGH Capital Management LLC managed an equity portfolio of $1.6B at the end of Q1 2026, spanning 43 distinct U.S. exchange-listed positions.
In Q1 2026, AIGH Capital Management LLC displayed an active expansion posture, initiating 18 new positions and adding to 14 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 20.29% | +0.60% | — | |
| 2 | SNDK | Sandisk CORP | Stock-Tech | 17.33% | +4.02% | -28.57% | |
| 3 | ZM | Zoom Communications Inc | Stock-Tech | 7.67% | -7.67% | EXIT | |
| 4 | XLK | Ss Technology Select Sector | ETF-Tech | 5.44% | -5.44% | EXIT | |
| 5 | TYGO | Tigo Energy Inc | Stock-Other | 3.73% | -3.44% | — | |
| 6 | SIMO | Silicon Motion Technol-adr | Stock-Other | 3.06% | -0.03% | — | |
| 7 | ZBRA | Zebra Technologies Corp-cl A | Stock-Tech | 2.85% | -2.85% | EXIT | |
| 8 | LASR | Nlight Inc | Stock-Other | 2.64% | -2.64% | EXIT | |
| 9 | VNDA | Vanda Pharmaceuticals Inc | Stock-Other | 2.59% | -1.80% | +37.61% | |
| 10 | PSNL | Personalis Inc | Stock-Other | 2.52% | -1.07% | — | |
| 11 | GNRC | Generac Holdings Inc | Stock-Industrials | 2.40% | -2.40% | EXIT | |
| 12 | KYTX | Kyverna Therapeutics Inc | Stock-Other | 2.35% | -0.78% | +33.33% | |
| 13 | CSTL | Castle Biosciences Inc | Stock-Other | 1.98% | -1.16% | -5.46% | |
| 14 | APPS | Digital Turbine Inc | Stock-Other | 1.92% | +3.40% | — | |
| 15 | RRX | Regal Rexnord CORP | Stock-Industrials | 1.92% | -1.92% | EXIT | |
| 16 | ABEO | Abeona Therapeutics Inc | Stock-Other | 1.89% | -0.73% | +55.00% | |
| 17 | LRMR | Larimar Therapeutics Inc | Stock-Other | 1.84% | -1.84% | EXIT | |
| 18 | FENC | Fennec Pharmaceuticals Inc | Stock-Other | 1.66% | +0.02% | +25.29% | |
| 19 | ESPR | Esperion Therapeutics Inc | Stock-Other | 1.64% | -1.64% | EXIT | |
| 20 | ZVRA | Zevra Therapeutics Inc | Stock-Other | 1.53% | -1.53% | EXIT | |
| 21 | BDSX | Biodesix Inc | Stock-Other | 1.50% | -0.54% | — | |
| 22 | IDN | Intellicheck Inc | Stock-Other | 1.45% | -1.45% | EXIT | |
| 23 | VSTM | Verastem Inc | Stock-Other | 1.45% | -0.99% | — | |
| 24 | TARA | Protara Therapeutic Inc | Stock-Other | 1.15% | -1.15% | EXIT | |
| 25 | VUZI | Vuzix CORP | Stock-Other | 1.04% | +0.19% | — | |
| 26 | ✓ | Polypid LTD | Stock-Other | 0.95% | -0.47% | +18.66% | |
| 27 | APYX | Apyx Medical CORP | Stock-Other | 0.56% | -0.24% | — | |
| 28 | COYA | Coya Therapeutics Inc | Stock-Other | 0.52% | -0.29% | — | |
| 29 | ELUT | Elutia Inc | Stock-Other | 0.51% | -0.34% | +17.18% | |
| 30 | RNXT | Renovorx Inc | Stock-Other | 0.50% | -0.23% | +30.78% | |
| 31 | TLPH | Talphera Inc | Stock-Other | 0.47% | -0.17% | — | |
| 32 | WATT | Energous CORP | Stock-Other | 0.46% | -0.18% | — | |
| 33 | IPWR | Ideal Power Inc | Stock-Other | 0.46% | -0.16% | +140.19% | |
| 34 | NRXS | Neuraxis Inc | Stock-Other | 0.40% | -0.16% | — | |
| 35 | BKTI | Bk Technologies CORP | Stock-Other | 0.33% | -0.33% | EXIT | |
| 36 | LPCN | Lipocine Inc | Stock-Other | 0.22% | -0.22% | EXIT | |
| 37 | INVE | Identiv Inc | Stock-Other | 0.21% | +0.02% | — | |
| 38 | LPTH | Lightpath Technologies Inc-a | Stock-Other | 0.14% | -0.14% | EXIT | |
| 39 | ✓ | Regentis Biomaterials LTD | Stock-Other | 0.12% | -0.12% | EXIT | |
| 40 | APRE | Aprea Therapeutics Inc | Stock-Other | 0.11% | -0.06% | +174.07% | |
| 41 | BFRI | Biofrontera Inc | Stock-Other | 0.10% | -0.06% | — | |
| 42 | QNRX | Quoin Pharmaceuticals Lt-adr | Stock-Other | 0.05% | -0.03% | +3.40% | |
| 43 | SMTK | Smartkem Inc | Stock-Other | 0.03% | -0.03% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SNDK | Sandisk CORP | +1.2% | -28.57% | Trim |
| 2 | IPWR | Ideal Power Inc | +0.1% | +140.19% | Add |
| 3 | APRE | Aprea Therapeutics Inc | 0% | +174.07% | Add |
| 4 | LRMR | Larimar Therapeutics Inc | — | +50.00% | Add |
| 5 | ELUT | Elutia Inc | — | +17.18% | Add |
| 6 | BFRI | Biofrontera Inc | 0% | — | Unchanged |
| 7 | NRXS | Neuraxis Inc | 0% | — | Unchanged |
| 8 | QNRX | Quoin Pharmaceuticals Lt-adr | -0.1% | +3.40% | Add |
| 9 | SMTK | Smartkem Inc | -0.1% | +32.66% | Add |
| 10 | APYX | Apyx Medical CORP | -0.4% | — | Unchanged |
| 11 | RNXT | Renovorx Inc | -0.4% | +30.78% | Add |
| 12 | ✓ | Polypid LTD | -0.5% | +18.66% | Add |
| 13 | IDN | Intellicheck Inc | -0.5% | +25.04% | Add |
| 14 | ABEO | Abeona Therapeutics Inc | -0.7% | +55.00% | Add |
| 15 | TLPH | Talphera Inc | -0.8% | — | Unchanged |
| 16 | COYA | Coya Therapeutics Inc | -0.9% | — | Unchanged |
| 17 | KYTX | Kyverna Therapeutics Inc | -1.1% | +33.33% | Add |
| 18 | FENC | Fennec Pharmaceuticals Inc | -1.3% | +25.29% | Add |
| 19 | VNDA | Vanda Pharmaceuticals Inc | -1.7% | +37.61% | Add |
| 20 | ESPR | Esperion Therapeutics Inc | -1.9% | +10.00% | Add |
| 21 | LPTH | Lightpath Technologies Inc-a | -2.6% | -90.30% | Trim |
| 22 | LASR | Nlight Inc | -2.8% | -43.34% | Trim |
| 23 | PSNL | Personalis Inc | -3.1% | — | Unchanged |
| 24 | BKTI | Bk Technologies CORP | -3.5% | -84.58% | Trim |
| 25 | CSTL | Castle Biosciences Inc | -3.9% | -5.46% | Trim |
| 26 | IWM | Ishares Russell 2000 ETF | — | NEW | New buy |
| 27 | ZM | Zoom Communications, Inc. | — | EXIT | Sold out |
| 28 | ZM | Zoom Communications Inc | — | NEW | New buy |
| 29 | XLK | Ss Technology Select Sector | — | NEW | New buy |
| 30 | TYGO | Tigo Energy Inc | — | NEW | New buy |
| 31 | SIMO | Silicon Motion Technol-adr | — | NEW | New buy |
| 32 | ZBRA | Zebra Technologies Corp-cl A | — | NEW | New buy |
| 33 | DAWNGBX | Day One Biopharmaceuticals I | — | EXIT | Sold out |
| 34 | GNRC | Generac Holdings Inc | — | NEW | New buy |
| 35 | DOMO | Domo Inc - Class B | — | EXIT | Sold out |
| 36 | APPS | Digital Turbine Inc | — | NEW | New buy |
| 37 | RRX | Regal Rexnord CORP | — | NEW | New buy |
| 38 | ZVRA | Zevra Therapeutics Inc | — | NEW | New buy |
| 39 | BDSX | Biodesix Inc | — | NEW | New buy |
| 40 | VSTM | Verastem Inc | — | NEW | New buy |
| 41 | ✓ | Zevra Therapeutics Inc | — | EXIT | Sold out |
| 42 | TARA | Protara Therapeutic Inc | — | NEW | New buy |
| 43 | VUZI | Vuzix CORP | — | NEW | New buy |
| 44 | ARQ | Arq Inc | — | EXIT | Sold out |
| 45 | ARDX | Ardelyx Inc | — | EXIT | Sold out |
| 46 | BYRN | Byrna Technologies Inc | — | EXIT | Sold out |
| 47 | STX | Seagate Technology Holdings plc | — | EXIT | Sold out |
| 48 | WATT | Energous CORP | — | NEW | New buy |
| 49 | GRCE | Grace Therapeutics Inc | — | EXIT | Sold out |
| 50 | LPCN | Lipocine Inc | — | NEW | New buy |
According to official SEC Form 13F filings, AIGH Capital Management LLC reported a total U.S. public equity portfolio value of $1.6B across 43 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IWM, SNDK, ZM) accounted for 25.2% of total reported equity market value during Q1 2026.
Top New Position Initiated
IWM
市值: $148.8M
Top Position Liquidated / Trimmed
ZM
前期市值: $60.4M
During Q1 2026, AIGH Capital Management LLC's top holdings by market value included IWM (20.3%)、SNDK (17.3%)、ZM (7.7%). The largest single position, IWM, represented 20.3% of total portfolio value.
In Q1 2026, AIGH Capital Management LLC made 46 total portfolio adjustments, initiating 18 new buys, adding to 14 positions, trimming 5 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.